A role for oleoylethanolamide in chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A role for oleoylethanolamide in chronic lymphocytic leukemia

Published:2014-01-13 Issue:7 Volume:28 Page:1381-1387
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Masoodi M,Lee E,Eiden M,Bahlo A,Shi Y,Ceddia R B,Baccei C,Prasit P,Spaner D E

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201410.pdf

Reference38 articles.

1. Foà R, Guarini A . A mechanism-driven treatment for CLL? N Engl J Med 2013; 369: 85–87.

2. Cramer P, Hallek M . Prognostic factors in CLL-what do we need to know? Nat Rev Clin Oncol 2011; 8: 38–47.

3. Spaner DE, Lee E, Shi Y, Wen F, Li Y, Tung S et al. PPARalpha is a therapeutic target for chronic lymphocytic leukemia. Leukemia 2013; 27: 1090–1099.

4. Masoodi M, Eiden M, Koulman A, Spaner D, Volmer DA . Comprehensive lipidomics analysis of bioactive lipids in complex regulatory networks. Anal Chem 2010; 82: 8176–8185.

5. Wong K, Brenneman F, Chesney A, Spaner D, Gorczynski R . Soluble CD200 is critical to engraft CLL cells in immunocompromised mice. Cancer Res 2012; 72: 4931–4943.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SMS121, a new inhibitor of CD36, impairs fatty acid uptake and viability of acute myeloid leukemia;Scientific Reports;2024-04-20

2. Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities;Progress in Lipid Research;2023-01

3. Expression of MUC-2, MUC-6, NAPE-PLD, IL-6 and IL-13 in Healthy and Metaplastic Bronchial Epithelium;Diseases;2022-12-27

4. Lipotoxicity as a Barrier for T Cell-Based Therapies;Biomolecules;2022-08-25

5. Identification of oleoylethanolamide as an endogenous ligand for HIF-3α;Nature Communications;2022-05-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3